Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
HIV-related cardiovascular disease and drug interactions
Kinjal A. Nanavati
,
Stacy D. Fisher
, Tracie L. Miller
, Steven E. Lipshultz
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'HIV-related cardiovascular disease and drug interactions'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cardiovascular Disease
100%
Disease Interaction
100%
HIV-related
100%
Cardiovascular Drugs
100%
Drug Interactions
100%
HIV-infected Patients
100%
Congestive Heart Failure
75%
HIV-associated
75%
Cardiovascular Complications
50%
Cardiovascular Involvement
50%
Highly Active Antiretroviral Therapy (HAART)
25%
Cardiovascular Manifestations
25%
HIV Infection
25%
Myocardial Infarction
25%
Public Health Risk
25%
Early Detection
25%
Dilated Cardiomyopathy
25%
Therapeutic Agents
25%
Premature Atherosclerosis
25%
Malignancy
25%
Arrhythmia
25%
Occult
25%
Adiposity
25%
Insulin Resistance
25%
Disease Process
25%
Dyslipidemia
25%
Immunomodulatory Therapy
25%
Accelerated Atherosclerosis
25%
Pericardial Effusion
25%
Pulmonary Arterial Hypertension
25%
Tamponade
25%
Lipodystrophy
25%
Ventricular Arrhythmia
25%
Vasculitis
25%
Global Public Health
25%
Left Ventricular Dysfunction
25%
Endocarditis
25%
Non-cardiovascular
25%
Associated Morbidity
25%
Supraventricular Arrhythmia
25%
Infective Endocarditis
25%
Physical Training
25%
Anti-infective Therapy
25%
Pulmonary Edema
25%
Physical Activity Program
25%
Patient-led
25%
Cardiovascular Emergencies
25%
Increased Awareness
25%
Independent Predictor of Mortality
25%
Routine Screening
25%
Torsades-de-Pointes
25%
Cardiovascular Problems
25%
Medicine and Dentistry
Cardiovascular Disease
100%
Human Immunodeficiency Virus
100%
Cardiovascular Agent
100%
Drug Interaction
100%
Cardiovascular System
75%
Congestive Heart Failure
37%
Atherosclerosis
25%
Morbidity
25%
Awareness
12%
Myocardial Infarction
12%
Hyperlipidemia
12%
Prematurity
12%
Public Health
12%
Dilated Cardiomyopathy
12%
Cancer
12%
Physical Activity
12%
Cardiac Dysrhythmia
12%
Heart Disease
12%
Human Immunodeficiency Virus Infection
12%
Pulmonary Hypertension
12%
Disease Process
12%
Dyslipidemia
12%
Heart Ventricle Arrhythmia
12%
Pericardial Fluid
12%
Vasculitis
12%
Highly Active Antiretroviral Therapy
12%
Lipodystrophy
12%
Pulmonary Edema
12%
Hope
12%
Insulin Resistance
12%
Heart Left Ventricle Failure
12%
Endocarditis
12%
Infective Endocarditis
12%
Heart Supraventricular Arrhythmia
12%
Torsade Des Pointes
12%
Tamponade
12%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Drug Interaction
100%
Cardiovascular Agent
100%
Cardiovascular Disease
100%
Congestive Heart Failure
37%
Atherosclerosis
25%
Morbidity
25%
Hyperlipidemia
12%
Prematurity
12%
Congestive Cardiomyopathy
12%
Heart Infarction
12%
Heart Disease
12%
Insulin Resistance
12%
Human Immunodeficiency Virus Infection
12%
Heart Arrhythmia
12%
Dyslipidemia
12%
Pulmonary Hypertension
12%
Torsade Des Pointes
12%
Lipodystrophy
12%
Heart Ventricle Arrhythmia
12%
Lung Edema
12%
Endocarditis
12%
Vasculitis
12%
Heart Left Ventricle Failure
12%
Heart Supraventricular Arrhythmia
12%
Bacterial Endocarditis
12%
Pericardial Effusion
12%